Literature DB >> 70410

Protective capacity of antibodies against Escherichia coli and K antigens.

B Kaijser, S Ahlstedt.   

Abstract

Antibodies to Escherichia coli O and K antigens were raised in rabbits by repeated immunizations with whole, Formalin-killed and, later, liver bacteria. The serum antibody levels were determined with the ammonium sulfate precipitation technique after radioiodinating the antigens. The K antigens had to be conjugated to proteins before labeling. Such conjugations were performed using cyanogen bromide for the K1 antigen and bisdiazobenzidine for the K13 antigen. The protective capacities of the rabbit antisera were tested in intraperitoneally infected mice. The protective capacity of the antisera was expressed per ammonium sulfate precipitation titer. The results showed a significantly higher protective effect for the antibodies against the K1 and K13 antigens than for the antibodies against the O2 and O6 lipopolysaccharides.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70410      PMCID: PMC421116          DOI: 10.1128/iai.17.2.286-289.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  ANTIBACTERIAL ANTIBODIES IN COLIFORM URINARY TRACT INFECTIONS.

Authors:  J WILLIAMSON; H BRAINERD; M SCAPARONE; S P CHUEH
Journal:  Arch Intern Med       Date:  1964-08

2.  A quantitative immunochemical measure of the primary interaction between I BSA and antibody.

Authors:  R S FARR
Journal:  J Infect Dis       Date:  1958 Nov-Dec       Impact factor: 5.226

3.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

4.  A slide microtechnique for the analysis of immune precipitates in gel.

Authors:  C WADSWORTH
Journal:  Int Arch Allergy Appl Immunol       Date:  1957

5.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

6.  K antigens of Escherichia coli and renal involvement in urinary-tract infections.

Authors:  A A Glynn; W Brumfitt; C J Howard
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

7.  Asymptomatic bacteriuria in schoolgirls. II. Differences in escherichia coli causing asymptomatic bacteriuria.

Authors:  U Lindberg; L A Hanson; U Jodal; G Lidin-Janson; K Lincoln; S Olling
Journal:  Acta Paediatr Scand       Date:  1975-05

8.  The immune response to urinary tract infections in childhood. I. Serological diagnosis of primary symptomatic infection in girls by indirect hemagglutination.

Authors:  U Jodal
Journal:  Acta Paediatr Scand       Date:  1975-01

9.  Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.

Authors:  S Ahlstedt; B Kaijser
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

10.  The role of immunity in the pathogenesis of experimental hematogenous pyelonephritis.

Authors:  J P SANFORD; B W HUNTER; L L SOUDA
Journal:  J Exp Med       Date:  1962-02-01       Impact factor: 14.307

View more
  30 in total

1.  Urinary antibody response after immunisation with a vaccine against urinary tract infection.

Authors:  D Kruze; K Holzbecher; M Andrial; W Bossart
Journal:  Urol Res       Date:  1989

2.  A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

Authors:  Thomas A Russo; Janet M Beanan; Ruth Olson; Stacy A Genagon; Ulrike MacDonald; John J Cope; Bruce A Davidson; Brian Johnston; James R Johnson
Journal:  Vaccine       Date:  2007-02-05       Impact factor: 3.641

Review 3.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

4.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

5.  Phagocytic resistance of Escherichia coli K-1 isolates and relationship to virulence.

Authors:  R Weinstein; L S Young
Journal:  J Clin Microbiol       Date:  1978-12       Impact factor: 5.948

6.  Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.

Authors:  B Kaijser; P Larsson; S Olling
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

7.  Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.

Authors:  T Söderström; L Ohman; K Stein; R Schneerson; W F Vann; L A Hanson
Journal:  Infection       Date:  1985       Impact factor: 3.553

8.  Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes.

Authors:  M Rozenberg-Arska; M E Salters; J A van Strijp; J J Geuze; J Verhoef
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes.

Authors:  E Lett; S Gangloff; M Zimmermann; D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

10.  Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement.

Authors:  R W Vreede; J H Marcelis; J Verhoef
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.